At kallisio, the company focuses on revolutionizing head & neck cancer care by safeguarding patients against the harmful effects of radiation therapy. They offer tailored immobilization and displacement solutions to manage radiation-induced harm, aiming to simplify points of care for patients and providers. Their innovative 3D printed patient-specific immobilization devices provide unparalleled protection to Organs at Risk (OARs) during radiation treatment, enabling better control of the patient therapy experience. Kallisio collaborates with MDACC to pioneer scalable solutions for precise patient immobilization and tongue deviation, with a goal to mitigate long-term side effects like mucositis, xerostomia, and dysphagia.